Blood transfusion requirements for patients undergoing chemotherapy for acute myeloid leukemia how much is enough?

Haematologica

Volumn 92, Issue 7, 2007, Pages 996-997

  Dawson, Mark A ^a,c,d   Avery, Sharon ^a   McQuilten, Zoe K ^a   Bailey, Michael J ^b   Shortt, Jake ^a,c   Polizzotto, Mark N ^a,c   Wood, Erica M ^c   Cole Sinclair, Merrole F ^a  

^a Alfred Pathology Service   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^d The Alfred   (Australia)

Author keywords

Acute myeloid leukemia; Blood transfusion; Chemotherapy

Indexed keywords

CYTARABINE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; FEMALE; HEALTH CARE PLANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PATIENT CARE; PRACTICE GUIDELINE; QUANTITATIVE ANALYSIS; RANK SUM TEST; STATISTICAL SIGNIFICANCE; ACUTE DISEASE; BLOOD DONOR; MIDDLE AGED; MYELOID LEUKEMIA; UTILIZATION REVIEW;

ACUTE DISEASE; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD DONORS; BLOOD TRANSFUSION; HUMANS; LEUKEMIA, MYELOID; MIDDLE AGED;

EID: 34548801832     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11019     Document Type: Article

References (6)

1. Milligan DW, Grimwade D, Cullis JO, Bond L, Swirsky D, Craddock C, et al. Guidelines on the management of acute myeloid leukaemia in adults. British Committee for Standards in Haematology. Br J Haematol 2006;135:450-74.
2. Bishop JF, Matthews JP, Young GA, Szer J, Gillett A, Joshua D, et al. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood 1996;87:1710-7.
3. Bradstock KF, Matthews JP, Lowenthal RM, Baxter H, Catalano J, Brighton T, et al. A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine. Blood 2005;105:481-8.
4. th ed. Council of Europe Publishing, 2006.
5. Clinical practice guidelines on the use of blood components: National Health and Medical Research Council/Australasian Society of Blood Transfusion. Available at: http://www.nhmrc.gov.au/publications/_files/cp78.pdf, 2001.
6. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100:2292-302.